Novo Nordisk diabetes drug appears effective for weight loss: studyNovo Nordisk's big-selling diabetes drug Victoza appears to be an effective weight loss therapy, data from a late-stage clinical trial presented on Saturday demonstrated. In the 56-week study of 846 overweight or obese adults with type 2 diabetes, a daily injection of 3 milligrams of Victoza led to significantly greater weight loss than did a placebo. Patients taking the 3 mg dose of the drug, known chemically as liraglutide, had a mean loss of 5.9 percent of body weight. The results were presented at the American Diabetes Association meeting in San Francisco.
Source: Novo Nordisk diabetes drug appears effective for weight loss: study (http://news.yahoo.com/novo-nordisk-diabetes-drug-appears-effective-weight-loss-154351337--finance.html)